Annals of Surgical Oncology

, Volume 16, Issue 8, pp 2377–2378 | Cite as

The Decisive Role of Surgeon’s Experience in Short-Term and Long-Term Oncological Outcomes and Quality of Life in Gastric Cancer

Gastrointestinal Oncology


  1. 1.
    Kappas AM, Roukos DH. Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol. 2002;9:828–30.PubMedCrossRefGoogle Scholar
  2. 2.
    Verlato G, Roviello F, Marchet A, et al. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol. 2009;16:594–602.PubMedCrossRefGoogle Scholar
  3. 3.
    Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–62.PubMedCrossRefGoogle Scholar
  4. 4.
    Liakakos T, Roukos DH. More controversy than ever—challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol. 2008;15:956–60.PubMedCrossRefGoogle Scholar
  5. 5.
    Ziogas D, Baltogiannis G, Fatouros M, Roukos DH. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg. 2008;247:714–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Roukos DH. Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn. 2009;9:1–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Fatouros M, Baltoyiannis G, Roukos DH. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol. 2008;15:21–33.PubMedCrossRefGoogle Scholar
  8. 8.
    Roukos DH. Linking contralateral breast cancer with genetics. Radiother Oncol. 2008;86:139–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Roukos DH. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. Expert Rev Mol Diagn. 2008;8:29–39.PubMedCrossRefGoogle Scholar
  10. 10.
    Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8:587–97.PubMedCrossRefGoogle Scholar
  11. 11.
    Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J Clin Oncol. 2008;26:4360–1.PubMedCrossRefGoogle Scholar
  12. 12.
    Roukos DH. HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med. 2008;358:197.PubMedCrossRefGoogle Scholar
  13. 13.
    Roukos DH. Breast-cancer stromal cells with TP53 mutations. N Engl J Med. 2008;358:1636.PubMedCrossRefGoogle Scholar
  14. 14.
    Roukos DH. Twenty-one-gene assay: challenges and promises in translating personal genomics and whole genome scans into personalized treatment of breast cancer. J Clin Oncol. 2009;27:1337–8.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  1. 1.Department of General SurgeryUniversity General Hospital of Heraklion, University of CreteHeraklionGreece
  2. 2.Department of Surgery, School of MedicineUniversity of IoanninaIoanninaGreece

Personalised recommendations